
Global Alzheimer's Disease Therapeutics and Diagnostics Market Research Report 2024(Status and Outlook)
Description
Global Alzheimer's Disease Therapeutics and Diagnostics Market Research Report 2024(Status and Outlook)
Report Overview:
Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.
The Global Alzheimer's Disease Therapeutics and Diagnostics Market Size was estimated at USD 3688.12 million in 2023 and is projected to reach USD 4032.75 million by 2029, exhibiting a CAGR of 1.50% during the forecast period.
This report provides a deep insight into the global Alzheimer's Disease Therapeutics and Diagnostics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Alzheimer's Disease Therapeutics and Diagnostics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Alzheimer's Disease Therapeutics and Diagnostics market in any manner.
Global Alzheimer's Disease Therapeutics and Diagnostics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Namenda
Aricept
Exelon
Solanezumab
Gantenerumab
Verubecestat
Pfizer
Eisai
Actavis
Lundbeck
Daiichi Sankyo
Novartis
TauRx
Market Segmentation (by Type)
Biomarkers
Cholinesterase inhibitors
NMDA receptor antagonists
Brain imaging
Blood tests
Market Segmentation (by Application)
Drugs Market
Diagnostics Market
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Alzheimer's Disease Therapeutics and Diagnostics Market
Overview of the regional outlook of the Alzheimer's Disease Therapeutics and Diagnostics Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Alzheimer's Disease Therapeutics and Diagnostics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Table of Contents
134 Pages
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Alzheimer's Disease Therapeutics and Diagnostics
- 1.2 Key Market Segments
- 1.2.1 Alzheimer's Disease Therapeutics and Diagnostics Segment by Type
- 1.2.2 Alzheimer's Disease Therapeutics and Diagnostics Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Alzheimer's Disease Therapeutics and Diagnostics Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Alzheimer's Disease Therapeutics and Diagnostics Market Size (M USD) Estimates and Forecasts (2019-2030)
- 2.1.2 Global Alzheimer's Disease Therapeutics and Diagnostics Sales Estimates and Forecasts (2019-2030)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Alzheimer's Disease Therapeutics and Diagnostics Market Competitive Landscape
- 3.1 Global Alzheimer's Disease Therapeutics and Diagnostics Sales by Manufacturers (2019-2024)
- 3.2 Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Market Share by Manufacturers (2019-2024)
- 3.3 Alzheimer's Disease Therapeutics and Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.4 Global Alzheimer's Disease Therapeutics and Diagnostics Average Price by Manufacturers (2019-2024)
- 3.5 Manufacturers Alzheimer's Disease Therapeutics and Diagnostics Sales Sites, Area Served, Product Type
- 3.6 Alzheimer's Disease Therapeutics and Diagnostics Market Competitive Situation and Trends
- 3.6.1 Alzheimer's Disease Therapeutics and Diagnostics Market Concentration Rate
- 3.6.2 Global 5 and 10 Largest Alzheimer's Disease Therapeutics and Diagnostics Players Market Share by Revenue
- 3.6.3 Mergers & Acquisitions, Expansion
- 4 Alzheimer's Disease Therapeutics and Diagnostics Industry Chain Analysis
- 4.1 Alzheimer's Disease Therapeutics and Diagnostics Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Alzheimer's Disease Therapeutics and Diagnostics Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Market Restraints
- 5.5 Industry News
- 5.5.1 New Product Developments
- 5.5.2 Mergers & Acquisitions
- 5.5.3 Expansions
- 5.5.4 Collaboration/Supply Contracts
- 5.6 Industry Policies
- 6 Alzheimer's Disease Therapeutics and Diagnostics Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Alzheimer's Disease Therapeutics and Diagnostics Sales Market Share by Type (2019-2024)
- 6.3 Global Alzheimer's Disease Therapeutics and Diagnostics Market Size Market Share by Type (2019-2024)
- 6.4 Global Alzheimer's Disease Therapeutics and Diagnostics Price by Type (2019-2024)
- 7 Alzheimer's Disease Therapeutics and Diagnostics Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Alzheimer's Disease Therapeutics and Diagnostics Market Sales by Application (2019-2024)
- 7.3 Global Alzheimer's Disease Therapeutics and Diagnostics Market Size (M USD) by Application (2019-2024)
- 7.4 Global Alzheimer's Disease Therapeutics and Diagnostics Sales Growth Rate by Application (2019-2024)
- 8 Alzheimer's Disease Therapeutics and Diagnostics Market Segmentation by Region
- 8.1 Global Alzheimer's Disease Therapeutics and Diagnostics Sales by Region
- 8.1.1 Global Alzheimer's Disease Therapeutics and Diagnostics Sales by Region
- 8.1.2 Global Alzheimer's Disease Therapeutics and Diagnostics Sales Market Share by Region
- 8.2 North America
- 8.2.1 North America Alzheimer's Disease Therapeutics and Diagnostics Sales by Country
- 8.2.2 U.S.
- 8.2.3 Canada
- 8.2.4 Mexico
- 8.3 Europe
- 8.3.1 Europe Alzheimer's Disease Therapeutics and Diagnostics Sales by Country
- 8.3.2 Germany
- 8.3.3 France
- 8.3.4 U.K.
- 8.3.5 Italy
- 8.3.6 Russia
- 8.4 Asia Pacific
- 8.4.1 Asia Pacific Alzheimer's Disease Therapeutics and Diagnostics Sales by Region
- 8.4.2 China
- 8.4.3 Japan
- 8.4.4 South Korea
- 8.4.5 India
- 8.4.6 Southeast Asia
- 8.5 South America
- 8.5.1 South America Alzheimer's Disease Therapeutics and Diagnostics Sales by Country
- 8.5.2 Brazil
- 8.5.3 Argentina
- 8.5.4 Columbia
- 8.6 Middle East and Africa
- 8.6.1 Middle East and Africa Alzheimer's Disease Therapeutics and Diagnostics Sales by Region
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Egypt
- 8.6.5 Nigeria
- 8.6.6 South Africa
- 9 Key Companies Profile
- 9.1 Namenda
- 9.1.1 Namenda Alzheimer's Disease Therapeutics and Diagnostics Basic Information
- 9.1.2 Namenda Alzheimer's Disease Therapeutics and Diagnostics Product Overview
- 9.1.3 Namenda Alzheimer's Disease Therapeutics and Diagnostics Product Market Performance
- 9.1.4 Namenda Business Overview
- 9.1.5 Namenda Alzheimer's Disease Therapeutics and Diagnostics SWOT Analysis
- 9.1.6 Namenda Recent Developments
- 9.2 Aricept
- 9.2.1 Aricept Alzheimer's Disease Therapeutics and Diagnostics Basic Information
- 9.2.2 Aricept Alzheimer's Disease Therapeutics and Diagnostics Product Overview
- 9.2.3 Aricept Alzheimer's Disease Therapeutics and Diagnostics Product Market Performance
- 9.2.4 Aricept Business Overview
- 9.2.5 Aricept Alzheimer's Disease Therapeutics and Diagnostics SWOT Analysis
- 9.2.6 Aricept Recent Developments
- 9.3 Exelon
- 9.3.1 Exelon Alzheimer's Disease Therapeutics and Diagnostics Basic Information
- 9.3.2 Exelon Alzheimer's Disease Therapeutics and Diagnostics Product Overview
- 9.3.3 Exelon Alzheimer's Disease Therapeutics and Diagnostics Product Market Performance
- 9.3.4 Exelon Alzheimer's Disease Therapeutics and Diagnostics SWOT Analysis
- 9.3.5 Exelon Business Overview
- 9.3.6 Exelon Recent Developments
- 9.4 Solanezumab
- 9.4.1 Solanezumab Alzheimer's Disease Therapeutics and Diagnostics Basic Information
- 9.4.2 Solanezumab Alzheimer's Disease Therapeutics and Diagnostics Product Overview
- 9.4.3 Solanezumab Alzheimer's Disease Therapeutics and Diagnostics Product Market Performance
- 9.4.4 Solanezumab Business Overview
- 9.4.5 Solanezumab Recent Developments
- 9.5 Gantenerumab
- 9.5.1 Gantenerumab Alzheimer's Disease Therapeutics and Diagnostics Basic Information
- 9.5.2 Gantenerumab Alzheimer's Disease Therapeutics and Diagnostics Product Overview
- 9.5.3 Gantenerumab Alzheimer's Disease Therapeutics and Diagnostics Product Market Performance
- 9.5.4 Gantenerumab Business Overview
- 9.5.5 Gantenerumab Recent Developments
- 9.6 Verubecestat
- 9.6.1 Verubecestat Alzheimer's Disease Therapeutics and Diagnostics Basic Information
- 9.6.2 Verubecestat Alzheimer's Disease Therapeutics and Diagnostics Product Overview
- 9.6.3 Verubecestat Alzheimer's Disease Therapeutics and Diagnostics Product Market Performance
- 9.6.4 Verubecestat Business Overview
- 9.6.5 Verubecestat Recent Developments
- 9.7 Pfizer
- 9.7.1 Pfizer Alzheimer's Disease Therapeutics and Diagnostics Basic Information
- 9.7.2 Pfizer Alzheimer's Disease Therapeutics and Diagnostics Product Overview
- 9.7.3 Pfizer Alzheimer's Disease Therapeutics and Diagnostics Product Market Performance
- 9.7.4 Pfizer Business Overview
- 9.7.5 Pfizer Recent Developments
- 9.8 Eisai
- 9.8.1 Eisai Alzheimer's Disease Therapeutics and Diagnostics Basic Information
- 9.8.2 Eisai Alzheimer's Disease Therapeutics and Diagnostics Product Overview
- 9.8.3 Eisai Alzheimer's Disease Therapeutics and Diagnostics Product Market Performance
- 9.8.4 Eisai Business Overview
- 9.8.5 Eisai Recent Developments
- 9.9 Actavis
- 9.9.1 Actavis Alzheimer's Disease Therapeutics and Diagnostics Basic Information
- 9.9.2 Actavis Alzheimer's Disease Therapeutics and Diagnostics Product Overview
- 9.9.3 Actavis Alzheimer's Disease Therapeutics and Diagnostics Product Market Performance
- 9.9.4 Actavis Business Overview
- 9.9.5 Actavis Recent Developments
- 9.10 Lundbeck
- 9.10.1 Lundbeck Alzheimer's Disease Therapeutics and Diagnostics Basic Information
- 9.10.2 Lundbeck Alzheimer's Disease Therapeutics and Diagnostics Product Overview
- 9.10.3 Lundbeck Alzheimer's Disease Therapeutics and Diagnostics Product Market Performance
- 9.10.4 Lundbeck Business Overview
- 9.10.5 Lundbeck Recent Developments
- 9.11 Daiichi Sankyo
- 9.11.1 Daiichi Sankyo Alzheimer's Disease Therapeutics and Diagnostics Basic Information
- 9.11.2 Daiichi Sankyo Alzheimer's Disease Therapeutics and Diagnostics Product Overview
- 9.11.3 Daiichi Sankyo Alzheimer's Disease Therapeutics and Diagnostics Product Market Performance
- 9.11.4 Daiichi Sankyo Business Overview
- 9.11.5 Daiichi Sankyo Recent Developments
- 9.12 Novartis
- 9.12.1 Novartis Alzheimer's Disease Therapeutics and Diagnostics Basic Information
- 9.12.2 Novartis Alzheimer's Disease Therapeutics and Diagnostics Product Overview
- 9.12.3 Novartis Alzheimer's Disease Therapeutics and Diagnostics Product Market Performance
- 9.12.4 Novartis Business Overview
- 9.12.5 Novartis Recent Developments
- 9.13 TauRx
- 9.13.1 TauRx Alzheimer's Disease Therapeutics and Diagnostics Basic Information
- 9.13.2 TauRx Alzheimer's Disease Therapeutics and Diagnostics Product Overview
- 9.13.3 TauRx Alzheimer's Disease Therapeutics and Diagnostics Product Market Performance
- 9.13.4 TauRx Business Overview
- 9.13.5 TauRx Recent Developments
- 10 Alzheimer's Disease Therapeutics and Diagnostics Market Forecast by Region
- 10.1 Global Alzheimer's Disease Therapeutics and Diagnostics Market Size Forecast
- 10.2 Global Alzheimer's Disease Therapeutics and Diagnostics Market Forecast by Region
- 10.2.1 North America Market Size Forecast by Country
- 10.2.2 Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size Forecast by Country
- 10.2.3 Asia Pacific Alzheimer's Disease Therapeutics and Diagnostics Market Size Forecast by Region
- 10.2.4 South America Alzheimer's Disease Therapeutics and Diagnostics Market Size Forecast by Country
- 10.2.5 Middle East and Africa Forecasted Consumption of Alzheimer's Disease Therapeutics and Diagnostics by Country
- 11 Forecast Market by Type and by Application (2025-2030)
- 11.1 Global Alzheimer's Disease Therapeutics and Diagnostics Market Forecast by Type (2025-2030)
- 11.1.1 Global Forecasted Sales of Alzheimer's Disease Therapeutics and Diagnostics by Type (2025-2030)
- 11.1.2 Global Alzheimer's Disease Therapeutics and Diagnostics Market Size Forecast by Type (2025-2030)
- 11.1.3 Global Forecasted Price of Alzheimer's Disease Therapeutics and Diagnostics by Type (2025-2030)
- 11.2 Global Alzheimer's Disease Therapeutics and Diagnostics Market Forecast by Application (2025-2030)
- 11.2.1 Global Alzheimer's Disease Therapeutics and Diagnostics Sales (K Units) Forecast by Application
- 11.2.2 Global Alzheimer's Disease Therapeutics and Diagnostics Market Size (M USD) Forecast by Application (2025-2030)
- 12 Conclusion and Key Findings
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.